Indrayani Biotech reports consolidated net loss of Rs 3.25 crore in the March 2021 quarter

Sales decline 50.24% to Rs 7.16 crore

Net loss of Indrayani Biotech reported to Rs 3.25 crore in the quarter ended March 2021 as against net profit of Rs 0.28 crore during the previous quarter ended March 2020. Sales declined 50.24% to Rs 7.16 crore in the quarter ended March 2021 as against Rs 14.39 crore during the previous quarter ended March 2020.

For the full year,net loss reported to Rs 11.21 crore in the year ended March 2021 as against net profit of Rs 0.81 crore during the previous year ended March 2020. Sales declined 57.74% to Rs 21.09 crore in the year ended March 2021 as against Rs 49.90 crore during the previous year ended March 2020.

ParticularsQuarter EndedYear EndedMar. 2021Mar. 2020% Var.Mar. 2021Mar. 2020% Var.Sales7.1614.39 -50 21.0949.90 -58 OPM %-7.966.25 --23.475.55 - PBDT-1.430.63 PL -6.651.82 PL PBT-1.240.28 PL -7.100.81 PL NP-3.250.28 PL -11.210.81 PL

Powered by Capital Market - Live News